Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Deloitte
UBS
Queensland Health
Express Scripts
Boehringer Ingelheim
Mallinckrodt
Medtronic
Healthtrust
Accenture

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040874

« Back to Dashboard

NDA 040874 describes DIPYRIDAMOLE, which is a drug marketed by Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Barr, Glenmark Generics, Idt Australia Ltd, Impax Labs, Lannett, Murty Pharms, Oxford Pharms, Purepac Pharm, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. It is available from ten suppliers. Additional details are available on the DIPYRIDAMOLE profile page.

The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.

Summary for 040874

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 040874

Physiological EffectDecreased Platelet Aggregation

Medical Subject Heading (MeSH) Categories for 040874

Suppliers and Packaging for NDA: 040874

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874 ANDA Cadila Healthcare Limited 65841-662 65841-662-01 100 TABLET, FILM COATED in 1 BOTTLE (65841-662-01)
DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874 ANDA Cadila Healthcare Limited 65841-662 65841-662-30 10 BLISTER PACK in 1 CARTON (65841-662-30) > 10 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Jan 28, 2008TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jan 28, 2008TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength75MG
Approval Date:Jan 28, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
UBS
Medtronic
Cerilliant
McKinsey
Colorcon
Harvard Business School
Novartis
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot